FuturHealth to Deliver Affordable, FDA-Approved GLP-1s Nationwide
As restrictions tighten on compounded semaglutide, FuturHealth now offers name-brand GLP-1s—like Wegovy®— through Novo’s cash-pay program FuturHealth, a leading provider of personalized weight-loss solutions, today announced it is giving its members seamless access to FDA-approved GLP-1 medications – including Wegovy® – at highly affordable, cash-pay prices, delivered directly to their doors. This service is enabled by the…
